Revelation Biosciences
REVB
6 hedge funds and large institutions have $656K invested in Revelation Biosciences in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
13% less capital invested
Capital invested by funds: $759K → $656K (-$102K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$61.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$44.1K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$39.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$26.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$63K |
| 2 |
HF
HRT Financial
New York
|
-$17K |
REVB Hedge Fund Activity: Q3 2023 in Review
6 of the 6,306 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q3 2023, worth a combined $656K — down 13% from $759K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new REVB positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Walleye Capital, adding an estimated $61.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $63K sold.
- 6 institutional investors held Revelation Biosciences (REVB) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $656K of Revelation Biosciences stock for Q3 2023, down 13% quarter-over-quarter.
- 3 funds opened new Revelation Biosciences positions in Q3 2023 and 2 closed out, a net change of +1 holder.
- The largest Revelation Biosciences buyer in Q3 2023 was Walleye Capital, an estimated $61.8K added.
- The largest Revelation Biosciences seller in Q3 2023 was Virtu Financial, an estimated $63K sold.
Based on aggregated 13F filings for Q3 2023.